Quantitative Imaging Biomarkers for Sarcoma

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Sarcoma
Interventions
PROCEDURE

DCE and DWI MRI

Dynamic Contrast Enhanced MRI (DCE-MRI) and Diffusion Weighted MRI (DW-MRI): DW-MRI is a technique for quantifying the increase in water diffusion caused by cellular necrosis or apoptosis in tumors within days of therapy. DCE-MRI is frequently used in preclinical and early clinical trial assessment of anti-angiogenic and vascular disrupting compounds, also within hours of therapeutic intervention.

PROCEDURE

Surgery

Standard of care procedure for sarcoma patients

Trial Locations (2)

10032

Columbia University Medical Center, New York

84112

Huntsman Cancer Institute, University of Utah, Salt Lake City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Columbia University

OTHER

NCT02579980 - Quantitative Imaging Biomarkers for Sarcoma | Biotech Hunter | Biotech Hunter